ClearSky expands team with key appointments

ClearSky expands team with key appointments

ClearSky Medical Diagnostics is delighted to announce the appointment of two new members of staff – Marta Vallejo and Amir Dehsarvi. Dr Vallejo has joined ClearSky in the newly-formed role of Head of AI and Machine Learning and will be responsible for the development...
How LD-Monitor can help save the NHS money

How LD-Monitor can help save the NHS money

Implementing ClearSky’s LID-Monitor in UK hospitals ‘has the potential to reduce costs to the NHS and increase the quality of life of people with Parkinson’s’… Parkinson’s is a progressive neurological condition – the second most common neurodegenerative disorder...
What is levodopa-induced dyskinesia?

What is levodopa-induced dyskinesia?

Levodopa is the most effective and commonly used drug for treating Parkinson’s. It is a chemical building-block that your body converts into dopamine. People with Parkinson’s lack enough dopamine because some of the brain cells that make it have died. The loss of...
What are evolutionary algorithms?

What are evolutionary algorithms?

ClearSky Medical Diagnostics’ portfolio of non-invasive devices for diagnosing and monitoring neurodegenerative conditions is based on unique biologically-inspired technology. We use a range of standard peripherals, including tablets, sensors, and data gloves, to...
ClearSky is heading to MEDICA 2017

ClearSky is heading to MEDICA 2017

ClearSky Medical Diagnostics is looking forward to attending and exhibiting at MEDICA 2017, the international medical trade fair. MEDICA is the world’s largest event for the medical sector – more than 128,000 international trade visitors from 70 countries attended the...
Dr Morris strengthens the ClearSky team

Dr Morris strengthens the ClearSky team

Dr Keith Morris has been appointed the Quality Assurance and Regulatory Affairs Counsel for ClearSky Medical Diagnostics. Keith has more than 20 years’ experience in the pharmaceutical, healthcare and medical industries and huge experience of regulatory and quality...